Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist
- DOI
- 10.1158/2159-8290.cd-17-0399
- Published
- 2017-10-01
- Container
- Cancer Discovery
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/2159-8290.cd-17-0399,
title = {Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist},
author = {Michael R. McKeown and M. Ryan Corces and Matthew L. Eaton and Chris Fiore and Emily Lee and Jeremy T. Lopez and Mei Wei Chen and Darren Smith and Steven M. Chan and Julie L. Koenig and Kathryn Austgen and Matthew G. Guenther and David A. Orlando and Jakob Lovén and Christian C. Fritz and Ravindra Majeti},
year = {2017},
journal = {Cancer Discovery},
doi = {10.1158/2159-8290.cd-17-0399},
url = {https://doi.org/10.1158/2159-8290.cd-17-0399}
}RIS
TY - JOUR TI - Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist AU - Michael R. McKeown AU - M. Ryan Corces AU - Matthew L. Eaton AU - Chris Fiore AU - Emily Lee AU - Jeremy T. Lopez AU - Mei Wei Chen AU - Darren Smith AU - Steven M. Chan AU - Julie L. Koenig AU - Kathryn Austgen AU - Matthew G. Guenther AU - David A. Orlando AU - Jakob Lovén AU - Christian C. Fritz AU - Ravindra Majeti PY - 2017 JO - Cancer Discovery DO - 10.1158/2159-8290.cd-17-0399 UR - https://doi.org/10.1158/2159-8290.cd-17-0399 ER -
APA
McKeown, M. R., Corces, M. R., Eaton, M. L., Fiore, C., Lee, E., Lopez, J. T., Chen, M. W., Smith, D., Chan, S. M., Koenig, J. L., Austgen, K., Guenther, M. G., Orlando, D. A., Lovén, J., Fritz, C. C., & Majeti, R. (2017). Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-17-0399
Source records
- crossref · retrieved 2026-09-26T18:18:51.073Z